Prospective, Randomized Phase III Trial of I.V. Vinflunine Plus Best Supportive Care as Second Line Therapy Versus Best Supportive Care After a Platinum-Containing Regimen, in Patients With Advanced Transitional Cell Carcinoma of Urothelial Tract.

Trial Profile

Prospective, Randomized Phase III Trial of I.V. Vinflunine Plus Best Supportive Care as Second Line Therapy Versus Best Supportive Care After a Platinum-Containing Regimen, in Patients With Advanced Transitional Cell Carcinoma of Urothelial Tract.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Feb 2013

At a glance

  • Drugs Vinflunine (Primary)
  • Indications Bladder cancer; Urogenital cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Apr 2010 Updated survival results presented at the 25th Annual Congress of the European Association of Urology.
    • 12 Jan 2010 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
    • 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top